Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,703,561
+$914,929 QoQ
Shares Held
705,461
+27.4% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Derivatives in ACAD
reported options exposure · as of Mar 31, 2024CallValue
$948,537
CallShares
51,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ACAD ranks #72 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ACAD
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,703,561 | 705,461 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,788,632 | 553,674 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,652,234 | 1,483,235 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,486,604 | 68,920 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,626,866 | 97,945 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,521,924 | 1,118,361 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,576,970 | 2,053,119 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $47,737,852 | 2,937,714 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $38,927,810 | 2,105,344 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $948,537 | 51,300 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $55,252,068 | 1,764,678 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,012,980 | 384,500 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $50,296,589 | 2,413,464 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $2,727,956 | 130,900 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $11,682,139 | 487,772 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $32,972,884 | 1,752,013 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,141,077 | 1,202,329 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,031,572 | 368,678 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,036,762 | 854,277 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,324,451 | 1,086,889 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,074,323 | 603,013 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $1,750,500 | 75,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $176,232 | 10,610 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,973,897 | 121,931 | Shares | Sole | 2021-08-16 | |
| 2021-06-30 | $3,048,750 | 125,000 | Call | Sole | 2021-08-16 | |
| 2021-03-31 | $304,440 | 11,800 | Shares | Sole | 2021-05-17 | |
| 2021-03-31 | $2,786,400 | 108,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $5,346,000 | 100,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $19,625,754 | 367,111 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $24,400,695 | 591,532 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $40,202,569 | 829,432 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $13,006,493 | 307,846 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||